We found 175 records for "Preclinical research"

Articles

Broadening the RWD conversation

26th November 2014

 Broadening the RWD conversationArticles

There can be few pharma CEOs who are not acutely aware of the data revolution exploding around them and the need to enhance their data analytics capabilities. But technical expertise...

Read more

How can pharma innovate in childhood and TYA cancer?

14th November 2014

 How can pharma innovate in childhood and TYA cancer? Articles

As cancers in children and teenagers are rare, there is little commercial incentive for pharma to invest in researching drugs in this sector. Dr Tim Ringrose speaks to specialist in...

Read more

Pre-competitive research: Don’t compete - collaborate!

6th November 2014

 Pre-competitive research: Don’t compete - collaborate!Articles

Pharma and other stakeholders in the health arena are increasingly aware of the benefits of working together in the pre-competitive phase to address common problems. The Pistoia Alliance works to...

Read more

Patients as partners in medicines development – the EUPATI project

17th October 2014

 Patients as partners in medicines development – the EUPATI projectArticles

As the head of EUPATI, a consortium of organisations working to put patients at the heart of drug R&D, Jan Geissler has seen first-hand how bringing patients and industry together...

Read more

News

JP Morgan: 2015 set to be a big year for advanced therapies

15th January 2015

 JP Morgan: 2015 set to be a big year for advanced therapiesNews

2014 was a watershed year for companies developing gene therapy and genome editing technologies, but 2015 is shaping up to be even better, according to speakers at this week's JP...

Read more

Novartis invests in gene-editing with Intellia

7th January 2015

 Novartis invests in gene-editing with IntelliaNews

Novartis has staked a claim to the hot topic of gene-editing using the CRSPR/Cas9 technology with an investment in recently-formed Intellia Therapeutics.Massachusetts based Intellia - which was only formed a...

Read more

Graphene technology helps deliver cancer drugs in sequence

7th January 2015

 Graphene technology helps deliver cancer drugs in sequenceNews

Wonder material graphene could be used in medicines of the future to deliver a 'one-two' hit to cancer cells.Graphene is a two-dimensional sheet of carbon that is only one atom...

Read more

BMS extends fibrosis research with Calibr collaboration

6th January 2015

 BMS extends fibrosis research with Calibr collaborationNews

Bristol-Myers Squibb has unveiled a new research collaboration in the area of anti-fibrotic therapies, an area tipped for huge market growth.The US pharma company is to work with the California...

Read more

White Papers

Connected data and the use of smartphone enabled apps in market research

11th July 2014

 Connected data and the use of smartphone enabled apps in market researchWhite Papers

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise...

Read more

Personalised Medicine – the Future of Blockbuster Pharma?

29th October 2013

 Personalised Medicine – the Future of Blockbuster Pharma?White Papers

The personalised medicine approach is rapidly becoming the new norm for pharmaceutical industry drug development and commercialisation, but it demands much more forward-thinking decision-making, as Phenestra outlines in its latest...

Read more

Round table transcript: Oncology shaping the future of personalised healthcare

2nd October 2013

 Round table transcript: Oncology shaping the future of personalised healthcareWhite Papers

Earlier this year pharmaphorum filmed a round table debate exploring how developments in personalised healthcare cancer treatments are defining the future for this area beyond oncology. In this white paper,...

Read more

Audio & Video

Part three: Oncology shaping the future of personalised healthcare

  In the third part of our video round table debate on how oncology is shaping the future of personalised healthcare, the expert panel focusses on the critical role that pharmaceutical...

Read more

Part two: Oncology shaping the future of personalised healthcare

  Continuing our round table debate on how oncology is shaping the future of personalised healthcare, the participants discuss how healthcare systems need to adapt to support delivery of targeted medicines...

Read more

Events

The World NSCLC Summit

27th January 2015 - 28th January 2015

The World NSCLC Summit

Skygenix proudly presents the Annual World NSCLC Summit, (Non-Small Cell Lung Cancer) taking place on January 27th and 28th in the Colonnade Hotel in Boston, USA. Over the two days, this...

Read more

4th Annual Clinical Development and Trials Asia Congress

27th January 2015 - 28th January 2015

4th Annual Clinical Development and Trials Asia Congress

Oxford Global Conferences are proud to present the 4th Annual Clinical Development and Trials Asia Congress co-located 5th Pharma R&D Asia Congress to be held on the 27th & 28th...

Read more

The Biologics Congress

2nd February 2015 - 3rd February 2015

The Biologics Congress

The Biologics market is evolving with the development of new products and therapies and is expected to hit $200 billion in the next few years. With growing commercial potential, good...

Read more

Disruptive Innovations Europe

10th February 2015 - 11th February 2015

Disruptive Innovations Europe

Welcome to DPharm Europe. We are delighted to take the only event dedicated to disruptive innovations to advance clinical trials to Europe. Event History It was a daunting task to develop the first...

Read more

Press Releases

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

5th February 2014

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

  Ashfield Commercial & Medical Services   redefines healthcare outsourcing to meet pharma’s challenges   03 February 2014: UDG Healthcare plc (formerly United Drug plc), a leading international provider of services to healthcare manufacturers...

Read more

Unique round table debate brings together key personalised healthcare stakeholders

1st October 2013

Unique round table debate brings together key personalised healthcare stakeholders

AstraZeneca and pharmaphorum media today announced the publication of a unique piece of thought leadership research, via a video round table debate entitled ‘Oncology shaping the future of personalised healthcare’,...

Read more